Coronado Biosciences Secures $14,118,534 New Financing Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=79f940c2-1426-4491-a4f9-ad307fd3be65&Preview=1 -
Date
1/20/2011 -
Company Name
Coronado Biosciences -
Mailing Address
45 Rockefeller Plaza New York, NY 10111 -
Company Description
Coronado Biosciences is a clinical stage biopharmaceutical company focused on making cancer care better. How do we define better? We hope to make cancer care safer and more easily tolerated with improved outcomes. -
Website
http://www.CoronadoBioSciences.com -
Transaction Type
Venture Equity -
Transaction Amount
$14,118,534 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes were not disclosed. Represents value of certain shares of the issuer’s preferred stock which were exchanged as consideration for the acquisition of certain assets. SEC regulatory filing. -
M&A Terms
-
Venture Investor
Undisclosed
